Results 91 to 100 of about 364,439 (227)

Sero-Surveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls

Indian Journal of Community Medicine, 2010
Background: Rubella vaccination is not yet included in National Immunization Schedule in India. Serosurvey is frequently used to assess epidemiologic pattern of Rubella in a community.
Sharma Hitt, Chowdhari Sunil, Raina Tilak, Bhardwaj Subodh, Namjoshi Gajanan, Parekh Sameer   +5 more
doaj  

Deficits in Long-Term Vaccine Immunity Among Childhood Cancer Survivors Despite Revaccination Programs

Vaccines
Background: Childhood cancer survivors (CCSs) often experience impaired humoral immunity because of cancer treatments that increase their susceptibility to vaccine-preventable diseases. This study aimed to assess the seroprevalence of tetanus and rubella
Alexander Zadruzny, Eva Tiselius, Tiia Lepp, Teodora Aktas, Teghesti Tecleab, Samuel Hellman, Maja Jahnmatz, Anna Nilsson   +7 more
doaj   +1 more source

Newer vaccines (measles-rubella, human papillomavirus, rotavirus, and pneumococcal conjugate vaccine) introduction: Experience from Northern India

International Journal of Noncommunicable Diseases, 2018
Vaccines are essential to ensure that the population is immune to certain diseases, and immunization is one of the most cost-effective interventions to prevent the occurrence of the diseases.
Madhu Gupta, Kanica Kaushal, Nikita Sharma, Atul Gupta, Abu Mohammad Bashar, Suresh Dalpath, Shivani Gupta, G B Singh   +7 more
doaj   +1 more source

Impact of delayed blood donation sample processing and testing on SARS‐CoV‐2 serological assay results in an evolving pandemic response

Transfusion, Volume 66, Issue 9, Page 1800-1810, September 2026.
Abstract Background The two largest US blood collection organizations led a multiphased, multicenter nationwide SARS‐CoV‐2 blood donor‐based serosurveillance program. The potential impact of delayed sample processing and prolonged refrigerated or frozen storage on anti‐SARS‐CoV‐2 antibody detection was investigated.
Marion C. Lanteri, Valerie Green, Hasan Sulaeman, Mars Stone, James Haynes, Clara Di Germanio, Sakina Smith, Patricia G. Villaflor, Jamel Groves, Phillip C. Williamson, Susan L. Stramer, Melissa M. Coughlin, Jefferson M. Jones, Eduard Grebe, Michael P. Busch, Paula Saa   +15 more
wiley   +1 more source

Short‐Term Safety of Concomitant Meningococcal B and National Immunisation Program Vaccines in Infants Aged < 15 Months: A Survey‐Based Surveillance Study

Medical Journal of Australia, Volume 224, Issue 9, September 2026.
ABSTRACT Objective To examine short‐term safety outcomes following vaccination at 2‐, 4‐, 6‐ and 12‐month timepoints, comparing infants receiving meningococcal B (MenB) vaccines concomitantly with National Immunisation Program (NIP) vaccines to those receiving vaccines at separate visits. Study Type Observational cohort survey study.
Thuy Nguyen, Evelyn C. S. Tay, Michael Dymock, Thomas L. Snelling, Lucy Dawes, Julie Marsh, Yue Wu, Alan Leeb, Nicholas Wood, Lucy Deng   +9 more
wiley   +1 more source

Living Evidence for Australian Pregnancy and Postnatal Care (LEAPP): Transforming the Australian Pregnancy and Postnatal Care Guidelines

Medical Journal of Australia, Volume 224, Issue 9, September 2026.
ABSTRACT Introduction The Living Evidence for Australian Pregnancy and Postnatal Care (LEAPP) program was established in 2023 to update and transition the Australian Pregnancy Care Guidelines into living guidelines and to establish new, living Australian Postnatal Care Guidelines.
Miranda S. Cumpston, Anneliese Arno, Shaira N. Baptista, Shannon Barnes, Zoe Bradfield, Samantha P. Chakraborty, Caroline S. E. Homer, Stefan C. Kane, Nisha Khot, Steve McDonald, Steven McGloughlin, Tanya Millard, Jeremy J. N. Oats, Loyal Pattuwage, Matthew Quigley, Abdulbasit Seid, Rachel Silk, Alecia Staines, Anneliese Synnot, Alison Teate, Heath White, Tari Turner, for the LEAPP Guideline Development Group   +22 more
wiley   +1 more source

Feasibility assessment of measles and rubella eradication

This report addresses the epidemiological aspects and feasibility of measles and rubella eradication and the potential resource requirements in response to the request of the Director-General at the Seventieth World Health Assembly held on May 31, 2017 ...
Turner, Nikki, Kretsinger, Katrina, Measles and Rubella Eradication Feasibility Assessment Workshop Participants, Moss, William J, O'Brien, Katherine L, SAGE Working Group on Measles and Rubella Vaccines, Shendale, Stephanie, Lindstrand, Ann, Goodman, Tracey   +8 more
core   +1 more source

On the Path to Measles and Rubella Elimination Following Rubella-Containing Vaccine Introduction, 2000–2023, Namibia

Vaccines
Introduction: The WHO Measles and Rubella Strategic Framework 2021–2030 within the Immunization Agenda 2030 includes both measles and rubella elimination goals and provides guidance to countries for planning and implementing the measles and rubella ...
Balcha G. Masresha, Messeret E. Shibeshi, Roselina de Wee, Nicholas Shapumba, Takudzwa Sayi, Susan E. Reef, James L. Goodson   +6 more
doaj   +1 more source

Rubella : also known as German measles [PDF]

Rubella, sometimes called \u201cGerman measles,\u201d is a contagious disease caused by a virus. Unlike measles, rubella almost never causes serious illness or complications in infants and young children.

core  

Rubella Vaccination [PDF]

Archives of Pediatrics & Adolescent Medicine, 1979
S R, Preblud, P I, Nieburg, A D, Brandling-Bennett, A R, Hinman, K L, Herrmann   +4 more
openaire   +6 more sources